Legal

Insider trading scam spurred by $11.2B Gilead deal earns a stretch in prison

A Florida man charged with insider trading on a major Gilead deal has turned over all of his profits — and then some — on his way to a one-year sentence in prison.

Back in 2011, Jay Fung, 42, got a tip from a friend and ex-Morgan Stanley broker Kevin Dowd about Gilead Sciences’ planned $11.2 billion buyout of Pharmasset. According to a Reuters story, Dowd had learned about the buyout from a director at Gilead who was a customer at his branch.

Fung then bought Pharmasset call options and shares just days before the acquisition was announced. Gilead bought the company at a 89% premium. Fung immediately sold the shares and options he bought post-acquisition and made more than $250,000 in profits, prosecutors said.

After cashing out, Fung paid Dowd $35,000 for the tip.

Dowd was later slapped with a criminal conspiracy charge, eventually settling with the SEC and getting probation.

Fung didn’t make out as well. Aside from his year in prison, Fung will be paying a $2,000 fine after forfeiting over $345,000 associated with the deal.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 35,300+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biotech Investment Analyst
SV Health Investors Boston, MA
Research Scientist - Disease Biology
Recursion Pharmaceuticals Salt Lake City, UT
Senior Scientist - Predictive Pharmacology
Recursion Pharmaceuticals Salt Lake City, UT
Director, Translational Sciences
Cadent Therapeutics Cambridge, MA
Director of Marketing
twoXAR Mountain View, CA

Visit Endpoints Careers ->